Protein L: A novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Zheng, Zhili ^a   Chinnasamy, Nachimuthu ^a   Morgan, Richard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CHIMERIC ANTIGEN RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN LIGHT CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; PHYCOERYTHRIN; POLYCLONAL ANTIBODY; PROTEIN L; REAGENT; RETROVIRUS VECTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; STREPTAVIDIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IG L BINDING PROTEIN, PEPTOSTREPTOCOCCUS; IG L-BINDING PROTEIN, PEPTOSTREPTOCOCCUS; IGG FC BINDING PROTEIN, STREPTOCOCCUS; IGG FC-BINDING PROTEIN, STREPTOCOCCUS; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; STAPHYLOCOCCUS PROTEIN A;

ARTICLE; BINDING SITE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; ANIMAL; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; METHODOLOGY; TITRIMETRY;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BINDING SITES; FLOW CYTOMETRY; HUMANS; INDICATORS AND REAGENTS; LYMPHOCYTES; MICE; RECEPTORS, ANTIGEN; RECOMBINANT PROTEINS; STAPHYLOCOCCAL PROTEIN A; TITRIMETRY;

EID: 84856769835     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-29     Document Type: Article

References (11)

1. Cooper LJ. Off-the-shelf T-cell therapy. Blood 2010, 116:4741-4743. 10.1182/blood-2010-10-308379, 21127184.
2. Gross G, Waks T, Eshhar Z. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci USA 1989, 86:10024-10028. 10.1073/pnas.86.24.10024, 298636, 2513569.
3. Dotti G, Savoldo B, Brenner M. Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?". Hum Gene Ther 2009, 20:1229-1239. 10.1089/hum.2009.142, 2829458, 19702437.
4. Jena B, Dotti G, Cooper LJ. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor. Blood 2010, 116:1035-1044. 10.1182/blood-2010-01-043737, 2938125, 20439624.
5. Zhao Y, Wang QJ, Yang S, Kochenderfer JN, Zheng Z, Zhong X, Sadelain M, Eshhar Z, Rosenberg SA, Morgan RA. A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J Immunol 2009, 183:5563-5574. 10.4049/jimmunol.0900447, 19843940.
6. Chinnasamy D, Yu Z, Theoret MR, Zhao Y, Shrimali RK, Morgan RA, Feldman SA, Restifo NP, Rosenberg SA. Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. J Clin Invest 2010, 120:3953-3968. 10.1172/JCI43490, 2964987, 20978347.
7. Burns WR, Zhao Y, Frankel TL, Hinrichs CS, Zheng Z, Xu H, Feldman SA, Ferrone S, Rosenberg SA, Morgan RA. A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Res 2010, 70:3027-3033. 10.1158/0008-5472.CAN-09-2824, 3245576, 20395199.
8. Kochenderfer JN, Feldman SA, Zhao Y, Xu H, Black MA, Morgan RA, Wilson WH, Rosenberg SA. Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. J Immunother 2009, 32:689-702. 10.1097/CJI.0b013e3181ac6138, 2747302, 19561539.
9. Nilson BH, Solomon A, Bjorck L, Akerstrom B. Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol Chem 1992, 267:2234-2239.
10. Bjorck L. Protein L. a novel bacterial cell wall protein with affinity for Ig L chains. J Immunol 1988, 140:1194-1197.
11. Nilson BH, Logdberg L, Kastern W, Bjorck L, Akerstrom B. Purification of antibodies using protein L-binding framework structures in the light chain variable domain. J Immunol Methods 1993, 164:33-40. 10.1016/0022-1759(93)90273-A, 8360508.